Updated Jul 16, 2026
Elston George has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
George Elston is the Chief Financial Officer of EyePoint Pharmaceuticals, Inc., a company focused on developing innovative therapeutics for serious retinal diseases. He has been involved in the financial management of the company, as indicated by his role and SEC filings.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-27 | EYPT | EyePoint, Inc. | F — Tax withholding / forfeiture | 3.6K | $12.93 | $47K |
| 2026-05-27 | EYPT | EyePoint, Inc. | M — Option exercise | 7.5K | $0.00 | |
| 2026-03-06 | EYPT | EyePoint, Inc. | G — Bona-fide gift | 5.0K | $0.00 | |
| 2026-03-06 | EYPT | EyePoint, Inc. | G — Bona-fide gift | 5.0K | $0.00 | |
| 2025-09-19 | EYPT | EyePoint, Inc. | G — Bona-fide gift | 20.0K | $0.00 | |
| 2025-09-19 | EYPT | EyePoint, Inc. | G — Bona-fide gift | 20.0K | $0.00 |
George Elston is the Chief Financial Officer of EyePoint Pharmaceuticals, Inc., a company focused on developing innovative therapeutics for serious retinal diseases. He has been involved in the financial management of the company, as indicated by his role and SEC filings.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Elston George profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.